Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.67 |
| ▸ | CALM1 | P0DP23 | 3/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29644736 | 1.00 | TAAR1 (0.67) | TAAR1CALM1CYP3A4CYP2D6CYP1A2 | |
| SCHEMBL79785 | 0.89 | CALM1 (0.64) | TAAR1CALM1CYP3A4CYP2D6CYP1A2 | |
| SCHEMBL5749606 | 0.88 | TAAR1 (0.54) | TAAR1CALM1CYP3A4CYP2D6CYP1A2 | |
| SCHEMBL3777135 | 0.88 | TAAR1 (0.52) | TAAR1CALM1CYP3A4CYP2D6ALDH1A1 | |
| SCHEMBL108087 | 0.87 | TAAR1 (0.77) | TAAR1CALM1CYP3A4CYP2D6CYP1A2 | |
| SCHEMBL5809247 | 0.87 | CALM1 (0.62) | TAAR1CALM1CYP3A4CYP2D6SLC6A4 | |
| SCHEMBL30101936 | 0.87 | CALM1 (0.62) | TAAR1CALM1CYP3A4CYP2D6SLC6A4 | |
| SCHEMBL26919 | 0.85 | HDAC1 (0.62) | TAAR1CALM1CYP3A4CYP2D6ALDH1A1 | |
| Hydrogen Sulfide SCHEMBL28114002 | 0.84 | HDAC1 (0.61) | TAAR1CALM1CYP3A4CYP2D6ALDH1A1 | |
| SCHEMBL108050 | 0.83 | CALM1 (0.72) | TAAR1CALM1CYP3A4CYP1A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9616459-B1 | Polymeric coatings for fortification of visible, infrared, and laser optical devices | LOCKHEED MARTIN CORPORATION (US) | 2017-04-11 | — | — | US | claimed |
| EP-2774909-B1 | Process for the preparation of hydroxytyrosol | WACKER CHEMIE AG (DE) | 2015-08-12 | — | — | EP | claimed |
| US-20140256989-A1 | PROCESS FOR THE PREPARATION OF HYDROXYTYROSOL | WACKER CHEMIE AG (DE) | 2014-09-11 | — | — | US | claimed |
| EP-2774909-A1 | Process for the preparation of hydroxytyrosol | Wacker Chemie AG (DE) | 2014-09-10 | — | — | EP | claimed |
| US-8822738-B1 | Process for the preparation of hydroxytyrosol | WACKER CHEMIE AG (DE) | 2014-09-02 | — | — | US | claimed |
| EP-4721745-A1 | COMBINED PRODUCT, SALT AND USE THEREOF | Shanghai Henlius Biotech, Inc. (CN) | 2026-04-08 | — | — | EP | disclosed |
| EP-4721740-A1 | COMBINATION PRODUCT, SALT, AND USE THEREOF IN TREATING NEURODEGENERATIVE DISEASES OR DISORDERS | Shanghai Henlius Biotech, Inc. (CN) | 2026-04-08 | — | — | EP | disclosed |
| US-20260078118-A1 | COMBINED PRODUCT, SALT AND USE THEREOF | SHANGHAI HENLIUS BIOTECH INC (CN) | 2026-03-19 | — | — | US | disclosed |
| US-20260076959-A1 | COMBINATION PRODUCT, SALT, AND USE THEREOF IN TREATING NEURODEGENERATIVE DISEASES OR DISORDERS | SHANGHAI HENLIUS BIOTECH INC (CN) | 2026-03-19 | — | — | US | disclosed |
| US-20260035381-A1 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | SUMITOMO PHARMA AMERICA, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| CN-115210239-B | Aromatic compound, organic semiconductor layer, and organic thin film transistor | 东曹株式会社 | 2025-04-11 | — | — | CN | disclosed |
| WO-2025016273-A1 | ISOQUINOLINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USES OF ISOQUINOLINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION | 拜西欧斯（北京）生物技术有限公司 | 2025-01-23 | — | — | WO | disclosed |
| EP-0350309-A1 | Piperidine derivatives | Pfizer Limited (GB) | 1990-01-10 | — | — | EP | disclosed |
| US-4729994-A | Benzothiazepine vasodilators having aralkyl substitution | MCNEILAB, INC. (US) | 1988-03-08 | — | — | US | disclosed |
| EP-0256888-A1 | Benzothiazepine vasodilators having aralkyl substitution | McNeilab, Inc. (US) | 1988-02-24 | — | — | EP | disclosed |
| US-4247560-A | 6,7-Methylenedioxy-isochromane arthropodicide synergizing agents | BAYER AKTIENGESELLSCHAFT (DE) | 1981-01-27 | — | — | US | disclosed |
| US-4059593-A | Synthesis of steganacin and derivatives thereof | UNIVERSITY OF ROCHESTER (US) | 1977-11-22 | — | — | US | disclosed |
| US-4058607-A | DIHALOVINYL DIALKYL PHOSPHATE, 1,3-BENZODIOXOLES | AIRWICK INDUSTRIES, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-4003916-A | ANTI-LEUKEMIC AGENTS; DIBENZO-CYCLOOCTADIENE LIGNIN LACTONES; SAPONIFICATION | KENDE ANDREW S | 1977-01-18 | — | — | US | disclosed |
| US-3962415-A | Insecticide evaporator comprising DDVP with synergized benzodioxole compound as stabilizer | AIRWICK INDUSTRIES, INC. (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035381-A1 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | ADH1C, HTR6, CNR1 | TAAR1 97/4885CALM1 284/4885CYP3A4 1078/4885 |
| US-20260076959-A1 | COMBINATION PRODUCT, SALT, AND USE THEREOF IN TREATING NEURODEGENERATIVE DISEASES OR DISORDERS | SLC10A1, CYP46A1, CYP27A1 | TAAR1 1017/4885CALM1 1271/4885CYP3A4 398/4885 |
| US-20140256989-A1 | PROCESS FOR THE PREPARATION OF HYDROXYTYROSOL | HCAR3, HCAR1, HCAR2 | TAAR1 30/4885CALM1 1791/4885CYP3A4 1211/4885 |
| US-20260078118-A1 | COMBINED PRODUCT, SALT AND USE THEREOF | SLC10A1, SLC10A2, CYP27A1 | TAAR1 1874/4885CALM1 4504/4885CYP3A4 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.